VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) was up 5.9% on Monday . The company traded as high as C$0.18 and last traded at C$0.18. Approximately 94,860 shares changed hands during trading, a decline of 67% from the average daily volume of 290,300 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Up 5.9 %
The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The company has a fifty day simple moving average of C$0.10 and a two-hundred day simple moving average of C$0.13. The firm has a market capitalization of C$29.20 million, a PE ratio of -5.56 and a beta of 0.39.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- The Most Important Warren Buffett Stock for Investors: His Own
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
- What Are Trending Stocks? Trending Stocks Explained
- Energy and Basic Materials Sectors Will Dominate in 2025
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
